Trials of adult stem cells are more common than embryonic research

08/2/2010 | Los Angeles Times (tiered subscription model)

The use of adult stem cells in clinical trials for the treatment of multiple sclerosis, blood diseases and other conditions has become more prevalent than embryonic stem cell studies because of the ethical debate surrounding embryo-derived cells. Although embryonic stem cells hold promise for the development of replacement tissues, such cells are more likely to be used in the near term as laboratory tools for identifying therapeutic compounds and studying the origins of diseases.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ